论文部分内容阅读
OBJECTIVE This study aimed to investigate the influence of IgD on T/B cell activation and construct h IgD-Fc-Igfusion protein to competitive inhibition IgD binding with IgDR.METHODS T/B cells were sorted by magnetic cell sorting.The differences of m IgD and IgD-R level between different T/B cell subtypes were detected by FCM.Serum IgD level was detected by ELISA.Human IgD-Fc-IgG1-Fc sequence was amplified by cross-PCR and then subcloned into PET28 a(+) empty vector.After prokaryotic expression through escherichia coli,we obtained the h IgD-Fc-Igfusion protein by affinity chromatograph.Western blot was used to identify the h IgD-Fc-Igfusion protein.Human peripheral blood monouclear cells(PBMC) and fibroblast like synoviocytes(FLS) proliferation were detected using a cell counting kit-8(CCK-8).RESULTS The percentage of CD3~+/CD4~+,CD3~+/IgD~+,CD3~+/CD4~+/IgD~+,CD3~+/IgD-R+and CD3~+/CD4~+/IgD-R+cells increased significantly in RA patients comparing to healthy people.IgD can stimulate PBMC proliferation.IgD(1,3,10,30 μg·mL~(-1)) stimulate PBMC proliferation significantly after 24 h.We obtained stable and active h IgD-Fc-Igfusion protein.The h IgD-Fc-Igfusion protein showed no effect on PBMC proliferation.But it could downregulate human IgD protein promoting proliferation effects in human PBMC.CONCLUSION This result suggests that IgD and IgDR play an important role on T/B cell activation in RA patients and the h IgD-Fc-Igfusion protein may competitively inhibit IgD′s function and may play an therapeutic role in autoimmune diseases.
OBJECTIVE This study aimed to investigate the influence of IgD on T / B cell activation and construct h IgD-Fc-Igfusion protein to competitive inhibition IgD binding with IgDR.METHODS T / B cells were sorted by magnetic cell sorting. Differences of m IgD and IgD-R level between different T / B cell subtypes were detected by FCM. Serum IgD level was detected by ELISA. Human IgD-Fc-IgG1-Fc sequence was amplified by cross-PCR and then subcloned into PET28 a vector.After prokaryotic expression through escherichia coli, we obtained the h IgD-Fc-Igfusion protein by affinity chromatograph. Western blot was used to identify the h IgD-Fc-Igfusion protein. Human peripheral blood monouclear cells (PBMC) and fibroblast like synoviocytes (FLS) proliferation were detected using a cell counting kit-8 (CCK-8) .RESULTS The percentage of CD3 ~ + / CD4 ~ +, CD3 ~ + / IgD ~ +, CD3 ~ + / CD4 ~ + / IgD ~ , CD3 ~ + / IgD-R + and CD3 ~ + / CD4 ~ + / IgD-R + cells increased significantly in RA patients compared to healthy people stimulation of PBMC proliferation significantly after 24 h.We obtained stable and active h IgD-Fc-Igfusion protein.The h IgD-Fc-Igfusion protein showed (1, 10, 10 μg · mL -1) no effect on PBMC proliferation.But it could downregulate human IgD protein promoting proliferation effects in human PBMC.CONCLUSION This result suggests that IgD and IgDR play an important role on T / B cell activation in RA patients and the h IgD-Fc-Igfusion protein may competitively inhibit IgD’s function and may play an therapeutic role in autoimmune diseases.